Macaques vaccinated with live-attenuated SIV control replication of heterologous virus

Matthew R. Reynolds, Andrea M. Weiler, Kim L. Weisgrau, Shari M. Piaskowski, Jessica R. Furlott, Jason T. Weinfurter, Masahiko Kaizu, Taeko Soma, Enrique J. León, Caitlin MacNair, Dan P. Leaman, Michael B. Zwick, Emma Gostick, Solomon K. Musani, David A. Price, Thomas C. Friedrich, Eva G. Rakasz, Nancy A. Wilson, Adrian B. McDermott, Rosanne BoyleDavid B. Allison, Dennis R. Burton, Wayne C. Koff, David Watkins

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

An effective AIDS vaccine will need to protect against globally diverse isolates of HIV. To address this issue in macaques, we administered a live-attenuated simian immunodeficiency virus (SIV) vaccine and challenged with a highly pathogenic heterologous isolate. Vaccinees reduced viral replication by ∼2 logs between weeks 2-32 (P ≤ 0.049) postchallenge. Remarkably, vaccinees expressing MHC-I (MHC class I) alleles previously associated with viral control completely suppressed acute phase replication of the challenge virus, implicating CD8 + T cells in this control. Furthermore, transient depletion of peripheral CD8 + lymphocytes in four vaccinees during the chronic phase resulted in an increase in virus replication. In two of these animals, the recrudescent virus population contained only the vaccine strain and not the challenge virus. Alarmingly, however, we found evidence of recombinant viruses emerging in some of the vaccinated animals. This finding argues strongly against an attenuated virus vaccine as a solution to the AIDS epidemic. On a more positive note, our results suggest that MHC-I-restricted CD8 + T cells contribute to the protection induced by the live-attenuated SIV vaccine and demonstrate that vaccine- induced CD8 + T cell responses can control replication of heterologous challenge viruses.

Original languageEnglish
Pages (from-to)2537-2550
Number of pages14
JournalJournal of Experimental Medicine
Volume205
Issue number11
DOIs
StatePublished - Oct 27 2008
Externally publishedYes

Fingerprint

Simian Immunodeficiency Virus
Macaca
Virus Replication
Viruses
Vaccines
T-Lymphocytes
AIDS Vaccines
Attenuated Vaccines
Acquired Immunodeficiency Syndrome
Alleles
HIV
Lymphocytes
Population

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Reynolds, M. R., Weiler, A. M., Weisgrau, K. L., Piaskowski, S. M., Furlott, J. R., Weinfurter, J. T., ... Watkins, D. (2008). Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. Journal of Experimental Medicine, 205(11), 2537-2550. https://doi.org/10.1084/jem.20081524

Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. / Reynolds, Matthew R.; Weiler, Andrea M.; Weisgrau, Kim L.; Piaskowski, Shari M.; Furlott, Jessica R.; Weinfurter, Jason T.; Kaizu, Masahiko; Soma, Taeko; León, Enrique J.; MacNair, Caitlin; Leaman, Dan P.; Zwick, Michael B.; Gostick, Emma; Musani, Solomon K.; Price, David A.; Friedrich, Thomas C.; Rakasz, Eva G.; Wilson, Nancy A.; McDermott, Adrian B.; Boyle, Rosanne; Allison, David B.; Burton, Dennis R.; Koff, Wayne C.; Watkins, David.

In: Journal of Experimental Medicine, Vol. 205, No. 11, 27.10.2008, p. 2537-2550.

Research output: Contribution to journalArticle

Reynolds, MR, Weiler, AM, Weisgrau, KL, Piaskowski, SM, Furlott, JR, Weinfurter, JT, Kaizu, M, Soma, T, León, EJ, MacNair, C, Leaman, DP, Zwick, MB, Gostick, E, Musani, SK, Price, DA, Friedrich, TC, Rakasz, EG, Wilson, NA, McDermott, AB, Boyle, R, Allison, DB, Burton, DR, Koff, WC & Watkins, D 2008, 'Macaques vaccinated with live-attenuated SIV control replication of heterologous virus', Journal of Experimental Medicine, vol. 205, no. 11, pp. 2537-2550. https://doi.org/10.1084/jem.20081524
Reynolds MR, Weiler AM, Weisgrau KL, Piaskowski SM, Furlott JR, Weinfurter JT et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. Journal of Experimental Medicine. 2008 Oct 27;205(11):2537-2550. https://doi.org/10.1084/jem.20081524
Reynolds, Matthew R. ; Weiler, Andrea M. ; Weisgrau, Kim L. ; Piaskowski, Shari M. ; Furlott, Jessica R. ; Weinfurter, Jason T. ; Kaizu, Masahiko ; Soma, Taeko ; León, Enrique J. ; MacNair, Caitlin ; Leaman, Dan P. ; Zwick, Michael B. ; Gostick, Emma ; Musani, Solomon K. ; Price, David A. ; Friedrich, Thomas C. ; Rakasz, Eva G. ; Wilson, Nancy A. ; McDermott, Adrian B. ; Boyle, Rosanne ; Allison, David B. ; Burton, Dennis R. ; Koff, Wayne C. ; Watkins, David. / Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. In: Journal of Experimental Medicine. 2008 ; Vol. 205, No. 11. pp. 2537-2550.
@article{09453f15c7a04e3996550aebd1796ea5,
title = "Macaques vaccinated with live-attenuated SIV control replication of heterologous virus",
abstract = "An effective AIDS vaccine will need to protect against globally diverse isolates of HIV. To address this issue in macaques, we administered a live-attenuated simian immunodeficiency virus (SIV) vaccine and challenged with a highly pathogenic heterologous isolate. Vaccinees reduced viral replication by ∼2 logs between weeks 2-32 (P ≤ 0.049) postchallenge. Remarkably, vaccinees expressing MHC-I (MHC class I) alleles previously associated with viral control completely suppressed acute phase replication of the challenge virus, implicating CD8 + T cells in this control. Furthermore, transient depletion of peripheral CD8 + lymphocytes in four vaccinees during the chronic phase resulted in an increase in virus replication. In two of these animals, the recrudescent virus population contained only the vaccine strain and not the challenge virus. Alarmingly, however, we found evidence of recombinant viruses emerging in some of the vaccinated animals. This finding argues strongly against an attenuated virus vaccine as a solution to the AIDS epidemic. On a more positive note, our results suggest that MHC-I-restricted CD8 + T cells contribute to the protection induced by the live-attenuated SIV vaccine and demonstrate that vaccine- induced CD8 + T cell responses can control replication of heterologous challenge viruses.",
author = "Reynolds, {Matthew R.} and Weiler, {Andrea M.} and Weisgrau, {Kim L.} and Piaskowski, {Shari M.} and Furlott, {Jessica R.} and Weinfurter, {Jason T.} and Masahiko Kaizu and Taeko Soma and Le{\'o}n, {Enrique J.} and Caitlin MacNair and Leaman, {Dan P.} and Zwick, {Michael B.} and Emma Gostick and Musani, {Solomon K.} and Price, {David A.} and Friedrich, {Thomas C.} and Rakasz, {Eva G.} and Wilson, {Nancy A.} and McDermott, {Adrian B.} and Rosanne Boyle and Allison, {David B.} and Burton, {Dennis R.} and Koff, {Wayne C.} and David Watkins",
year = "2008",
month = "10",
day = "27",
doi = "10.1084/jem.20081524",
language = "English",
volume = "205",
pages = "2537--2550",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "11",

}

TY - JOUR

T1 - Macaques vaccinated with live-attenuated SIV control replication of heterologous virus

AU - Reynolds, Matthew R.

AU - Weiler, Andrea M.

AU - Weisgrau, Kim L.

AU - Piaskowski, Shari M.

AU - Furlott, Jessica R.

AU - Weinfurter, Jason T.

AU - Kaizu, Masahiko

AU - Soma, Taeko

AU - León, Enrique J.

AU - MacNair, Caitlin

AU - Leaman, Dan P.

AU - Zwick, Michael B.

AU - Gostick, Emma

AU - Musani, Solomon K.

AU - Price, David A.

AU - Friedrich, Thomas C.

AU - Rakasz, Eva G.

AU - Wilson, Nancy A.

AU - McDermott, Adrian B.

AU - Boyle, Rosanne

AU - Allison, David B.

AU - Burton, Dennis R.

AU - Koff, Wayne C.

AU - Watkins, David

PY - 2008/10/27

Y1 - 2008/10/27

N2 - An effective AIDS vaccine will need to protect against globally diverse isolates of HIV. To address this issue in macaques, we administered a live-attenuated simian immunodeficiency virus (SIV) vaccine and challenged with a highly pathogenic heterologous isolate. Vaccinees reduced viral replication by ∼2 logs between weeks 2-32 (P ≤ 0.049) postchallenge. Remarkably, vaccinees expressing MHC-I (MHC class I) alleles previously associated with viral control completely suppressed acute phase replication of the challenge virus, implicating CD8 + T cells in this control. Furthermore, transient depletion of peripheral CD8 + lymphocytes in four vaccinees during the chronic phase resulted in an increase in virus replication. In two of these animals, the recrudescent virus population contained only the vaccine strain and not the challenge virus. Alarmingly, however, we found evidence of recombinant viruses emerging in some of the vaccinated animals. This finding argues strongly against an attenuated virus vaccine as a solution to the AIDS epidemic. On a more positive note, our results suggest that MHC-I-restricted CD8 + T cells contribute to the protection induced by the live-attenuated SIV vaccine and demonstrate that vaccine- induced CD8 + T cell responses can control replication of heterologous challenge viruses.

AB - An effective AIDS vaccine will need to protect against globally diverse isolates of HIV. To address this issue in macaques, we administered a live-attenuated simian immunodeficiency virus (SIV) vaccine and challenged with a highly pathogenic heterologous isolate. Vaccinees reduced viral replication by ∼2 logs between weeks 2-32 (P ≤ 0.049) postchallenge. Remarkably, vaccinees expressing MHC-I (MHC class I) alleles previously associated with viral control completely suppressed acute phase replication of the challenge virus, implicating CD8 + T cells in this control. Furthermore, transient depletion of peripheral CD8 + lymphocytes in four vaccinees during the chronic phase resulted in an increase in virus replication. In two of these animals, the recrudescent virus population contained only the vaccine strain and not the challenge virus. Alarmingly, however, we found evidence of recombinant viruses emerging in some of the vaccinated animals. This finding argues strongly against an attenuated virus vaccine as a solution to the AIDS epidemic. On a more positive note, our results suggest that MHC-I-restricted CD8 + T cells contribute to the protection induced by the live-attenuated SIV vaccine and demonstrate that vaccine- induced CD8 + T cell responses can control replication of heterologous challenge viruses.

UR - http://www.scopus.com/inward/record.url?scp=58149143041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149143041&partnerID=8YFLogxK

U2 - 10.1084/jem.20081524

DO - 10.1084/jem.20081524

M3 - Article

C2 - 18838548

AN - SCOPUS:58149143041

VL - 205

SP - 2537

EP - 2550

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 11

ER -